MedTrace Logo

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

NCT02437851 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-04-20

No results posted yet for this study

Summary

This phase II trial studies surgery in treating patients with anal canal or perianal cancer that is small and has not spread deeply into the tissues and human immunodeficiency virus (HIV) infection. Local surgery may be a safer treatment with fewer side effects than bigger surgery or radiation and chemotherapy.

Conditions

  • Anal Squamous Cell Carcinoma
  • HIV Infection
  • Stage 0 Anal Canal Cancer
  • Stage I Anal Canal Cancer

Interventions

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery to remove anal or perianal cancer (SISCCA)

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • AIDS and Cancer Specimen Resource

    collaborator OTHER

  • University of Arkansas

    collaborator OTHER

  • AIDS Malignancy Consortium

    lead NETWORK

Principal Investigators

  • Stephen Goldstone · AIDS Associated Malignancies Clinical Trials Consortium

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2026-04-15
Completion
2026-04-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02437851 on ClinicalTrials.gov